A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

Introduction: Two standard single-agent chemotherapy treatments (docetaxel and pemetrexed) were combined in this trial and administered as second-line treatment in patients with non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the safety and feasibility of combining docetaxe...

Full description

Bibliographic Details
Main Authors: Vinzenz Kroeber, Sylke Nagel, Wolfgang Schuette, Thomas Blankenburg
Format: Article
Language:English
Published: Karger Publishers 2014-07-01
Series:Case Reports in Oncology
Subjects:
Docetaxel
Pemetrexed
Non-small cell lung cancer
Second-line chemotherapy
Combination chemotherapy
Online Access:http://www.karger.com/Article/FullText/365323

Internet

http://www.karger.com/Article/FullText/365323

Similar Items